KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Shareholder's Equity Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 48.06%
Dec 31, 2025 47.32%
Sep 30, 2025 27.79%
Jun 30, 2025 25.37%
Mar 31, 2025 23.60%
Dec 31, 2024 -5.70%
Sep 30, 2024 -1.68%
Jun 30, 2024 -12.62%
Mar 31, 2024 -6.10%
Dec 31, 2023 70.23%
Sep 30, 2023 109.58%
Jun 30, 2023 180.32%
Mar 31, 2023 483.84%
Dec 31, 2022 -45.36%
Sep 30, 2022 -55.54%
Jun 30, 2022 -70.67%
Mar 31, 2022 -90.19%
Dec 31, 2021 -28.79%
Sep 30, 2021 -25.02%
Jun 30, 2021 -22.63%
Mar 31, 2021 -1.59%
Dec 31, 2020 -2.73%
Sep 30, 2020 0.29%
Jun 30, 2020 -1.25%
Mar 31, 2020 -12.44%
Dec 31, 2019 -22.62%
Sep 30, 2019 -23.85%
Jun 30, 2019 -27.60%
Mar 31, 2019 -30.65%
Dec 31, 2018 -50.48%
Sep 30, 2018 -55.48%
Jun 30, 2018 14,809.00%
Mar 31, 2018 4,414.92%
Dec 31, 2017 -15.51%
Sep 30, 2017 4.73%
Jun 30, 2017 -64.54%
Mar 31, 2017 -406.78%
Dec 31, 2016 6.38%
Sep 30, 2016 10.03%
Jun 30, 2016 -98.97%
Mar 31, 2016 -99.55%
Dec 31, 2015 8.94%
Sep 30, 2015 10.43%
Jun 30, 2015 12.72%
Mar 31, 2015 16.56%
Dec 31, 2014 16.66%
Sep 30, 2014 16.55%
Jun 30, 2014 18.39%
Mar 31, 2014 16.67%
Dec 31, 2013 15.93%
Sep 30, 2013 9.17%
Dec 31, 2012 0.16%
Sep 30, 2012 -15.50%
Dec 31, 2011 -20.53%
Sep 30, 2011 -2.15%
Jun 30, 2011 10.55%
Mar 31, 2011 11.84%
Dec 31, 2010 5.63%
Sep 30, 2010 5.31%
Jun 30, 2010 8.47%